comparemela.com

Latest Breaking News On - Pramod amthe - Page 1 : comparemela.com

23,000 or 25,000? Here s where experts see Indian benchmark Nifty 50 by FY25-end

With markets extending its bullish momentum in the new financial year FY 25. How much can the benchmark index Nifty 50 surge this financial year with the focus on upcoming elections as well as hopes of a rate cut in the latter half? Here s what analysts predict.

Nifty Bank vs Nifty IT: Which index should you invest in for long term?

With the March quarter earnings and elections as the next major trend, let s analyse between Nifty Bank and Nifty IT, which sector has better long-term investment opportunities.

market froth: Is the market getting bloated again? Pramod Amthe answers

Pramod Amthe discusses market recovery exceeding expectations, emerging opportunities in mid and smallcap stocks. He says one should have a cautious approach towards real estate, a selective view on energy and metals sectors. The emphasis should be on specific stock picks due to the favorable risk-reward ratios that they offer.

pharma stocks: Pramod Amthe is selective in midcaps; betting on 4 pharma stocks

The better way to play pharma is Sun Pharma and Aurobindo which we like. The other trend is domestic outlook for the growth for pharma. The proxy there is Torrent and Ajanta.Railways have new avenues of growth and strong momentum. Medium-term targets and government support improve growth prospects. Larger railway stocks like Concor, Kalpataru, and KEC are attractive due to their involvement in electrification lines. Having said that, some of the mid and smallcaps have run up much sharper.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.